| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |